BCL2 and acute promyelocytic leukemia: To verify these findings in the clinic, we analyzed the mRNA expression of BCL2 in seven APL primary mononuclear cell cultures collected from leukemia patients at disease presentation by quantitative RT-PCR (qRT-PCR).